TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment Local Bounti Q1 2026 Earnings EPS Beats Estimate Stock Declines on Limited Disclosure ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline CHA Q4 2025 Earnings Massive EPS Miss Sends Shares Lower EGAN Q1 2026 Earnings Strong EPS Beat Highlights Profitability Improvement